Growth factors profile in conditioned medium human adipose tissue-derived mesenchymal stem cells (CM-hATMSCs)-Reference-Cited by-同舟云学术

Growth factors profile in conditioned medium human adipose tissue-derived mesenchymal stem cells (CM-hATMSCs)

Published:2019-04 Issue: Volume:24 Page:34-44
ISSN:2352-9393
Container-title:Clinical Nutrition Experimental
language:en
Short-container-title:Clinical Nutrition Experimental

Author:

Noverina Rachmawati,Widowati Wahyu^ORCID,Ayuningtyas Wireni,Kurniawan Dedy,Afifah Ervi,Laksmitawati Dian Ratih,Rinendyaputri Ratih,Rilianawati Rilianawati,Faried Ahmad,Bachtiar Indra,Wirakusumah Firman Fuad

Funder

Insinas Riset Pratama

Ministry of Research, Technology and Higher Education of the Republic of Indonesia

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism

Reference55 articles.

1. Human mesenchymal stem cells: from basic biology to clinical applications;Abdallah;Gene Ther,2008

2. Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood;Bieback;Bio Med Mater Eng,2008

4. Effect of adipose-derived stem cell-conditioned medium on the proliferation and migration of B16 melanoma cells;Lee;Oncol Lett,2015

5. Efficacious and clinically relevant conditioned-medium of human adipose-derived stem cells for therapeutic angiogenesis;Bhang;Mol Ther,2014

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Umbilical cord mesenchymal stem cells: A powerful fighter against colon cancer?;Tissue and Cell;2024-10

2. Role of Adipose-Derived Mesenchymal Stem Cells in Bone Regeneration;International Journal of Molecular Sciences;2024-06-20

3. Umbilical cord mesenchymal stem cells and lung cancer: We should be hopeful or hopeless?;Tissue and Cell;2024-06

4. Modern aspects of external application and prospects of using the secretome of mesenchymal stem cells (review);Drug development & registration;2024-03-25

5. Autologous Fat Transfer in Craniofacial Surgery;FACE;2024-03-11